focus -WSS

focus

author：entertainment 2025-10-02 00:41:07 - browse：499

Illustration of a laptop on top of a TV with a hand sticking out, holding a newspaper. -- coverage from STAT — Adobe

WASHINGTON – If you live in this city, you’re probably awash in pharmacy benefit manager ads — whether you’re listening to an NPR podcast, reading the New York Times, streaming “Yellowstone,” or watching the U.S. Open Golf Championships. It doesn’t matter if it’s 5 a.m., primetime, or 11 p.m.; in between ads for dog joint supplements and the “Barbie” movie, you will inevitably learn about these middlemen of the prescription drug market.

Ads eviscerating and glorifying PBMs have been around for years. But they’ve intensified over the past three months as Congress scrutinizes PBMs’ role in shaping high drug prices. Over a half-dozen U.S. House and Senate Committees have started investigating PBMs, advancing bipartisan legislation to increase transparency in the industry; ban PBMs from charging more for a drug than what they pay (and pocketing the difference); and require them to pass all fees, rebates, and other payments they receive to insurers.

Lobbying groups have responded to this legislative push with dueling campaigns in the court of public opinion. On one side is the Pharmaceutical Care Management Association, the trade association representing PBMs, which argues that pharmaceutical companies are responsible for high drug prices. On the other side is the industry group PhRMA, which points the finger right back, saying that PBMs are really to blame. Both trade associations have launched ad campaigns worth millions of dollars, blanketing TV, radio, social media, print, and beyond.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Choosing scientific sides in the fight against Alzheimer's

focus

entertainment

WSS

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

The painfully weak evidence on taking collagen to treat arthritis

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Childhood vaccination ad campaign launches in the U.K.

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

entertainment

focus

Wikipedia

Virginia high school admissions case could be legal follow

Astronauts get first look at the spacecraft that will fly them around the moon

BioMarin wins approval for gene therapy to treat hemophilia A

In venture capital firm's success, lessons for turning crisis into profit

23andMe had bad news about my health. I wish a person had delivered it

'Vaccine

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Supreme Court strikes down use of affirmative action

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

knowledge

Former Georgia lieutenant governor says he received grand jury subpoena

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

Are embryos people? Reproductive medicine's future depends on the answer

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

More regulation could be coming for drug ads

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

focus

leisure time

entertainment

Wikipedia